Eli Lilly and Company

LLY · Moat type: REGULIERUNG

MoatScore

9/10

Fair Value

1,088 USD

Margin of Safety

-7.4 %

Rating

BEOBACHTEN

Eli Lilly develops, manufactures, and distributes patent-protected pharmaceutical products in global growth markets—particularly diabetes, obesity, and oncology—whereby profit is primarily secured through high pricing power on blockbuster active ingredients during patent duration and through a continuously replenished development pipeline.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.